Aygestin: Uses, dosage, side effects, warnings & patient reviews

What is Aygestin (Norethindrone Acetate)?

Aygestin is a prescription progestin medication containing the active ingredient norethindrone acetate. It is a synthetic progestin with progesterone-like effects, classified under women’s health therapies.

It works by mimicking some effects of natural progesterone in the body. Primarily, it transforms the uterine lining (endometrium) from a proliferative to a secretory state and can suppress ovulation-related hormonal signaling. This action is used in selected gynecologic conditions that respond to progestin therapy.

The medication is available in oral tablet form, with Aygestin 5 mg being a common dosage strength. FDA-approved generic versions (norethindrone acetate) are also available; inactive ingredients may differ between products.

How to Take Aygestin

Aygestin must be taken exactly as prescribed by a healthcare provider. Dosage and administration schedules vary depending on the condition being treated and individual clinical factors.

Administration

Tablets are taken orally, with or without food. Taking the medication at the same time each day may help support consistent exposure and reduce breakthrough bleeding in some patients.

For abnormal uterine bleeding or secondary amenorrhea, Aygestin may be prescribed for a defined number of days (for example, 5 to 10 days). A withdrawal bleed may occur after stopping the medication.

For endometriosis, Aygestin may be used as a daily regimen. Dosing is individualized and may be adjusted under medical supervision. Treatment may continue for months when clinically appropriate.

Important Precautions

Do not start Aygestin if you are pregnant or suspect you might be pregnant. If you miss a dose, take it as soon as you remember on the same day. If it is close to the time of your next dose, skip the missed dose and resume your regular schedule. Do not take two doses to make up for a missed one. Store the tablets at room temperature away from moisture and heat.

Side Effects of Aygestin

Like other hormone therapies, Aygestin can cause side effects. Their frequency and severity vary among individuals.

What is Aygestin Used For?

Aygestin is FDA-approved for specific gynecologic conditions related to hormonal imbalance.

Primary Medical Uses

• Endometriosis: Aygestin is indicated for the management of pain and other symptoms associated with endometriosis. It may help reduce symptoms by suppressing hormonally responsive endometrial-like tissue. An alternative treatment option for this condition is danazol.
• Abnormal Uterine Bleeding: It is prescribed to treat abnormal uterine bleeding due to a hormonal imbalance (not due to underlying organic pathology).
• Secondary Amenorrhea: Aygestin is used to treat the absence of menstrual periods (amenorrhea) in women who have previously had a menstrual cycle.

Other Uses (Off-label)

Under a doctor’s direction, Aygestin may also be used for purposes not explicitly approved by the FDA, such as menstrual suppression, management of premenstrual syndrome (PMS) symptoms, or period timing management in selected situations. The dosage and duration for such uses differ from approved indications and should be clinician-directed.

Important Safety Concerns and Considerations

Thromboembolic Disorders

Hormonal therapies, including some progestins, may be associated with thromboembolic and cardiovascular risks in susceptible patients. Risk can be higher in the presence of additional factors such as smoking, older age, obesity, prolonged immobilization, or a personal/family history of clotting disorders. Patients should be alert for symptoms such as leg pain/swelling, chest pain, or sudden shortness of breath.

Carcinogenesis

Some studies report associations between current use of certain hormonal therapies and breast cancer risk, but findings vary by population and regimen. Aygestin is contraindicated in women with known or suspected carcinoma of the breast.

Liver Function and Disease

Aygestin is metabolized by the liver. It should not be used in patients with acute or chronic significant liver disease or with liver tumors. Liver function tests may become abnormal during therapy.

Undiagnosed Abnormal Genital Bleeding

Aygestin should not be used to treat abnormal uterine bleeding until a clinician has evaluated the cause and ruled out non-hormonal causes, such as malignancy or pregnancy.

Fluid Retention

Because progestins may cause some degree of fluid retention, the drug should be prescribed with caution to patients with conditions that might be influenced by this factor, such as epilepsy, migraine, asthma, or cardiac or renal dysfunction.

Critical Warnings for Aygestin Use

Thromboembolic Disease

If an arterial or venous thrombotic event (e.g., stroke, myocardial infarction, deep vein thrombosis, pulmonary embolism) is suspected, seek urgent medical evaluation. Do not take additional doses until you receive medical advice.

Ophthalmic Effects

Seek urgent medical evaluation if there is sudden onset of proptosis, diplopia, migraine, or sudden partial or complete loss of vision. Retinal vascular lesions have been reported with progestin use.

Cigarette Smoking

Cigarette smoking may increase cardiovascular risk in people using hormonal therapy. Risk generally increases with age and with heavier smoking. If you smoke, discuss risk-reduction options with a healthcare professional. For more on associated risks, see information on cerebrovascular disease.

Elevated Blood Pressure

An increase in blood pressure has been reported in women taking progestins. Blood pressure may be monitored during therapy, especially in patients with pre-existing hypertension.

Carbohydrate and Lipid Metabolic Effects

Progestins may decrease glucose tolerance. Diabetic patients may require closer monitoring. Norethindrone acetate may also affect lipid parameters, including a decrease in HDL cholesterol.

Aygestin Dosage Information

Dosage is individualized based on the condition being treated and patient response. The regimens below are educational examples from prescribing sources and are not instructions for starting or changing therapy without medical supervision.

Important Administration Notes

• Timing: For cyclic therapy, dosing is often scheduled during the latter part of the cycle, depending on the indication and clinician plan.
• Duration: Longer courses (e.g., for endometriosis) require ongoing medical supervision to reassess benefits and risks.
• Dosage Forms: Available as 5 mg tablets. Tablet splitting should only be done if instructed by a doctor or pharmacist.

Drug Interactions with Aygestin

Several substances can alter blood levels or clinical effects of Aygestin. Inform your doctor about all medications and supplements you use.

Additional Information

Mechanism and Pharmacokinetics

Norethindrone acetate is a progestin with primarily progestational and weak androgenic activity. It is absorbed after oral administration and is converted to norethindrone. Reported half-life values vary by study and formulation, and the drug is metabolized in the liver with metabolites excreted in urine and bile.

Historical and Regulatory Context

Norethindrone (the active metabolite of norethindrone acetate) was an early synthesized progestin and contributed to the development of oral hormonal therapies. Aygestin has long been used for specific gynecologic indications under FDA regulation.

Obtaining Medication Safely

Aygestin is a prescription-only medication. It should only be obtained with a valid prescription from a licensed healthcare provider following an appropriate medical evaluation to confirm the diagnosis and review contraindications and risks.

References and Medical Sources

The information on this page is compiled from prescribing information and selected medical references.

1. U.S. Food and Drug Administration (FDA). Aygestin (norethindrone acetate) Tablets Prescribing Information. [Revised 2007]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018405s023lbl.pdf
2. MedlinePlus. Norethindrone. U.S. National Library of Medicine; [Updated 2022]. https://medlineplus.gov/druginfo/meds/a604034.html
3. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 114: Management of Endometriosis. Obstetrics & Gynecology. 2010;116(1):223-236.
4. Drugs.com. Norethindrone Acetate Professional Monograph. Drugs.com; [Updated 2024]. https://www.drugs.com/monograph/norethindrone-acetate.html

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.